#India #COVID #covaxin $OCGN


Ocugen-partnered COVID-19 vaccine shows efficacy against new variant behind India’s second wave

For COVID-19 vaccine developers, it could be even a bigger concern. India has so far authorized three vaccines: Covaxin developed by Bharat Biotech, Covishield, the Indian manufactured COVID-19 vaccine of AstraZeneca (NASDAQ:AZN

No replys yet!

It seems that this publication does not yet have any comments. In order to respond to this publication from User , click on ionicons-v5-n at the bottom under it